Doris A. Phelps

1.7k total citations
36 papers, 1.3k citations indexed

About

Doris A. Phelps is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Doris A. Phelps has authored 36 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 13 papers in Pulmonary and Respiratory Medicine and 10 papers in Oncology. Recurrent topics in Doris A. Phelps's work include Sarcoma Diagnosis and Treatment (9 papers), Neuroblastoma Research and Treatments (6 papers) and CAR-T cell therapy research (5 papers). Doris A. Phelps is often cited by papers focused on Sarcoma Diagnosis and Treatment (9 papers), Neuroblastoma Research and Treatments (6 papers) and CAR-T cell therapy research (5 papers). Doris A. Phelps collaborates with scholars based in United States, Australia and United Kingdom. Doris A. Phelps's co-authors include Peter J. Houghton, Neyssa Marina, Charles R. Crawford, J A Belt, Malcolm A. Smith, Christopher L. Morton, Hemant K. Bid, Raushan T. Kurmasheva, Geoffrey Neale and C. Patrick Reynolds and has published in prestigious journals such as PLoS ONE, Biochemistry and Cancer Research.

In The Last Decade

Doris A. Phelps

36 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Doris A. Phelps United States 20 832 362 236 197 155 36 1.3k
Rouslan Kotchetkov Canada 19 1.3k 1.5× 867 2.4× 108 0.5× 208 1.1× 159 1.0× 47 2.0k
Maddalena Arigoni Italy 24 789 0.9× 267 0.7× 201 0.9× 431 2.2× 89 0.6× 65 1.4k
Graham Steers United Kingdom 17 1.0k 1.2× 348 1.0× 126 0.5× 481 2.4× 67 0.4× 24 1.6k
Huong Muzik Canada 15 839 1.0× 622 1.7× 68 0.3× 369 1.9× 29 0.2× 22 1.4k
Jan van Riggelen United States 17 1.3k 1.6× 483 1.3× 77 0.3× 333 1.7× 46 0.3× 20 1.7k
William K. Dahlberg United States 18 836 1.0× 369 1.0× 206 0.9× 337 1.7× 53 0.3× 36 1.3k
Jerry Y. Hsu United States 17 1.8k 2.1× 723 2.0× 373 1.6× 199 1.0× 43 0.3× 43 2.3k
Madhavi Bandi United States 11 1.2k 1.5× 734 2.0× 58 0.2× 224 1.1× 49 0.3× 20 1.9k
J. Whang‐Peng United States 22 1.1k 1.3× 867 2.4× 295 1.3× 327 1.7× 123 0.8× 46 2.2k
Toshiki Mori Japan 16 1.6k 1.9× 868 2.4× 112 0.5× 301 1.5× 117 0.8× 24 2.4k

Countries citing papers authored by Doris A. Phelps

Since Specialization
Citations

This map shows the geographic impact of Doris A. Phelps's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doris A. Phelps with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doris A. Phelps more than expected).

Fields of papers citing papers by Doris A. Phelps

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Doris A. Phelps. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doris A. Phelps. The network helps show where Doris A. Phelps may publish in the future.

Co-authorship network of co-authors of Doris A. Phelps

This figure shows the co-authorship network connecting the top 25 collaborators of Doris A. Phelps. A scholar is included among the top collaborators of Doris A. Phelps based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Doris A. Phelps. Doris A. Phelps is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shackleford, Terry J., Angelina V. Vaseva, Hemant K. Bid, et al.. (2023). Redundant Signaling as the Predominant Mechanism for Resistance to Antibodies Targeting the Type-I Insulin-Like Growth Factor Receptor in Cells Derived from Childhood Sarcoma. Molecular Cancer Therapeutics. 22(4). 539–550. 5 indexed citations
2.
Gargollo, Patricio C., Mohamed E. Ahmed, Yohan Kim, et al.. (2021). Surfaceome Profiling of Rhabdomyosarcoma Reveals B7-H3 as a Mediator of Immune Evasion. Cancers. 13(18). 4528–4528. 19 indexed citations
3.
Robles, Andrew J., Raushan T. Kurmasheva, Abhik Bandyopadhyay, et al.. (2020). Evaluation of Eribulin Combined with Irinotecan for Treatment of Pediatric Cancer Xenografts. Clinical Cancer Research. 26(12). 3012–3023. 11 indexed citations
4.
Gross, Amy C., Hakan Çam, Doris A. Phelps, et al.. (2018). IL-6 and CXCL8 mediate osteosarcoma-lung interactions critical to metastasis. JCI Insight. 3(16). 62 indexed citations
5.
Bid, Hemant K., Doris A. Phelps, Denis C. Guttridge, et al.. (2016). The Bromodomain BET Inhibitor JQ1 Suppresses Tumor Angiogenesis in Models of Childhood Sarcoma. Molecular Cancer Therapeutics. 15(5). 1018–1028. 66 indexed citations
6.
Shen, Changxian, Doris A. Phelps, Hakan Çam, et al.. (2013). Regulation of FANCD2 by the mTOR Pathway Contributes to the Resistance of Cancer Cells to DNA Double-Strand Breaks. Cancer Research. 73(11). 3393–3401. 74 indexed citations
7.
Bid, Hemant K., Doris A. Phelps, Linlin Xiao, et al.. (2013). Development, Characterization, and Reversal of Acquired Resistance to the MEK1 Inhibitor Selumetinib (AZD6244) in an In Vivo Model of Childhood Astrocytoma. Clinical Cancer Research. 19(24). 6716–6729. 49 indexed citations
8.
Bid, Hemant K., Jun Zhan, Doris A. Phelps, Raushan T. Kurmasheva, & Peter J. Houghton. (2011). Potent Inhibition of Angiogenesis by the IGF-1 Receptor-Targeting Antibody SCH717454 Is Reversed by IGF-2. Molecular Cancer Therapeutics. 11(3). 649–659. 57 indexed citations
9.
Houghton, Peter J., Richard Görlick, E. Anders Kolb, et al.. (2011). Initial testing (stage 1) of the mTOR kinase inhibitor AZD8055 by the pediatric preclinical testing program. Pediatric Blood & Cancer. 58(2). 191–199. 37 indexed citations
10.
Kolb, E. Anders, Richard Görlick, Peter J. Houghton, et al.. (2010). Initial testing (stage 1) of AZD6244 (ARRY‐142886) by the pediatric preclinical testing program. Pediatric Blood & Cancer. 55(4). 668–677. 77 indexed citations
11.
Houghton, Peter J., Richard B. Lock, Hernán Carol, et al.. (2010). Initial testing of the hypoxia‐activated prodrug PR‐104 by the pediatric preclinical testing program. Pediatric Blood & Cancer. 57(3). 443–453. 23 indexed citations
12.
Görlick, Richard, E. Anders Kolb, Peter J. Houghton, et al.. (2009). Initial testing (stage 1) of lapatinib by the pediatric preclinical testing program. Pediatric Blood & Cancer. 53(4). 594–598. 26 indexed citations
13.
Neale, Geoffrey, Xiaoping Su, Christopher L. Morton, et al.. (2008). Molecular Characterization of the Pediatric Preclinical Testing Panel. Clinical Cancer Research. 14(14). 4572–4583. 95 indexed citations
14.
15.
Smith, Malcolm A., Christopher L. Morton, Doris A. Phelps, et al.. (2008). Stage 1 testing and pharmacodynamic evaluation of the HSP90 inhibitor alvespimycin (17‐DMAG, KOS‐1022) by the pediatric preclinical testing program. Pediatric Blood & Cancer. 51(1). 34–41. 26 indexed citations
16.
Kurmasheva, Raushan T., et al.. (2007). Combination of CP-751871, a human monoclonal antibody against the IGF-1 receptor, with rapamycin results in a highly effective therapy for xenografts derived from childhood sarcomas. Molecular Cancer Therapeutics. 6. 6 indexed citations
17.
Aboody, Karen S., Elizabeth Garcia, Marianne Z. Metz, et al.. (2006). Development of a Tumor-Selective Approach to Treat Metastatic Cancer. PLoS ONE. 1(1). e23–e23. 108 indexed citations
18.
Smith, Malcolm A., et al.. (2006). SK‐NEP‐1 and Rh1 are Ewing family tumor lines. Pediatric Blood & Cancer. 50(3). 703–706. 53 indexed citations
19.
Belt, J A, Neyssa Marina, Doris A. Phelps, & Charles R. Crawford. (1993). Nucleoside transport in normal and neoplastic cells. Advances in Enzyme Regulation. 33. 235–252. 146 indexed citations
20.
Sreekrishna, Koti, W. Richard McCombie, Lynn P. Nelles, et al.. (1988). High level expression of heterologous proteins in methylotrophic yeast Pichia pastoris. Journal of Basic Microbiology. 28(4). 265–278. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rouslan Kotchetkov Breakdown of academic impact, for papers by Maddalena Arigoni Breakdown of academic impact, for papers by Graham Steers Breakdown of academic impact, for papers by Huong Muzik Breakdown of academic impact, for papers by Jan van Riggelen Breakdown of academic impact, for papers by William K. Dahlberg Breakdown of academic impact, for papers by Jerry Y. Hsu Breakdown of academic impact, for papers by Madhavi Bandi Breakdown of academic impact, for papers by J. Whang‐Peng Breakdown of academic impact, for papers by Toshiki Mori
Rankless by CCL
2026